Creating a device to automatically count tissue stem cells
Design and production of an automated electronic tissue stem cell counter
['FUNDING_SBIR_2'] · ASYMMETREX, LLC · NIH-10914530
This study is working on a new tool that can automatically count tissue stem cells, which are important for treatments like stem cell transplants, to help make sure patients get the right amount and improve their chances of success.
Quick facts
| Phase | ['FUNDING_SBIR_2'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | ASYMMETREX, LLC (nih funded) |
| Locations | 1 site (BOSTON, UNITED STATES) |
| Trial ID | NIH-10914530 on ClinicalTrials.gov |
What this research studies
This research focuses on developing an innovative laboratory instrument that can automatically count tissue stem cells (TSCs), which are crucial for various stem cell therapies. Currently, there is no device available that can perform this task, leading to uncertainty in the number of stem cells administered during treatments. By providing accurate counts of stem cells, this technology aims to enhance patient outcomes in stem cell transplantation and improve the design of clinical trials. The project builds on previous successful methods to ensure reliable and efficient counting of these vital cells.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients undergoing stem cell transplantation or participating in clinical trials involving stem cell therapies.
Not a fit: Patients who are not receiving stem cell treatments or are not involved in related clinical trials may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more precise stem cell therapies, improving treatment outcomes for patients receiving stem cell transplants.
How similar studies have performed: Previous research has shown success in developing methods for counting stem cells, but this automated approach is novel and untested.
Where this research is happening
BOSTON, UNITED STATES
- ASYMMETREX, LLC — BOSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SHERLEY, JAMES L — ASYMMETREX, LLC
- Study coordinator: SHERLEY, JAMES L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancers